ZA200103321B - Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-phenylpiperidin-1-YL)-1-propanol and intermediates useful therefor. - Google Patents

Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-phenylpiperidin-1-YL)-1-propanol and intermediates useful therefor.

Info

Publication number
ZA200103321B
ZA200103321B ZA200103321A ZA200103321A ZA200103321B ZA 200103321 B ZA200103321 B ZA 200103321B ZA 200103321 A ZA200103321 A ZA 200103321A ZA 200103321 A ZA200103321 A ZA 200103321A ZA 200103321 B ZA200103321 B ZA 200103321B
Authority
ZA
South Africa
Prior art keywords
phenylpiperidin
hydroxyphenyl
propanol
hydroxy
preparation
Prior art date
Application number
ZA200103321A
Other languages
English (en)
Inventor
Joseph Philip Rainville
Terry Gene Sinay Jr
Stanley Walter Walinsky
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200103321B publication Critical patent/ZA200103321B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA200103321A 2000-04-28 2001-04-24 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-phenylpiperidin-1-YL)-1-propanol and intermediates useful therefor. ZA200103321B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20041700P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
ZA200103321B true ZA200103321B (en) 2002-10-24

Family

ID=22741639

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200103321A ZA200103321B (en) 2000-04-28 2001-04-24 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-phenylpiperidin-1-YL)-1-propanol and intermediates useful therefor.

Country Status (26)

Country Link
US (1) US6570018B2 (es)
EP (1) EP1149831B1 (es)
JP (1) JP2001354650A (es)
KR (1) KR100432841B1 (es)
CN (1) CN1211366C (es)
AR (1) AR028377A1 (es)
AT (1) ATE275130T1 (es)
AU (1) AU781715B2 (es)
BR (1) BR0101611A (es)
CA (1) CA2345286C (es)
CZ (1) CZ20011472A3 (es)
DE (1) DE60105221T2 (es)
DK (1) DK1149831T3 (es)
ES (1) ES2225425T3 (es)
HK (1) HK1040514B (es)
HU (1) HUP0101725A3 (es)
ID (1) ID30012A (es)
IL (1) IL142706A0 (es)
IN (1) IN191534B (es)
PL (1) PL347299A1 (es)
PT (1) PT1149831E (es)
RU (1) RU2192415C1 (es)
SI (1) SI1149831T1 (es)
TW (1) TWI222440B (es)
YU (1) YU27801A (es)
ZA (1) ZA200103321B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743921B2 (en) * 2002-01-24 2004-06-01 Dsm Catalytica Pharmaceuticals, Inc. Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds
CN105037221B (zh) * 2015-06-18 2017-05-10 吉林大学珠海学院 一种具有神经保护作用的化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199800208T1 (es) 1995-08-11 1998-05-21 Pfizer Inc.
TW450807B (en) * 1995-09-15 2001-08-21 Pfizer Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents

Also Published As

Publication number Publication date
SI1149831T1 (en) 2005-02-28
ES2225425T3 (es) 2005-03-16
DK1149831T3 (da) 2004-12-06
TWI222440B (en) 2004-10-21
AU781715B2 (en) 2005-06-09
RU2192415C1 (ru) 2002-11-10
CZ20011472A3 (cs) 2001-12-12
ID30012A (id) 2001-11-01
EP1149831B1 (en) 2004-09-01
IN191534B (es) 2003-12-06
HUP0101725A2 (hu) 2002-02-28
DE60105221D1 (de) 2004-10-07
DE60105221T2 (de) 2005-09-15
PL347299A1 (en) 2001-11-05
BR0101611A (pt) 2002-01-15
EP1149831A1 (en) 2001-10-31
AR028377A1 (es) 2003-05-07
US20020016466A1 (en) 2002-02-07
CN1322716A (zh) 2001-11-21
JP2001354650A (ja) 2001-12-25
KR100432841B1 (ko) 2004-05-24
CN1211366C (zh) 2005-07-20
AU3889701A (en) 2001-12-13
HUP0101725A3 (en) 2003-04-28
HK1040514B (zh) 2005-10-28
KR20010098924A (ko) 2001-11-08
CA2345286A1 (en) 2001-10-28
PT1149831E (pt) 2004-11-30
IL142706A0 (en) 2002-03-10
HU0101725D0 (en) 2001-07-30
US6570018B2 (en) 2003-05-27
ATE275130T1 (de) 2004-09-15
HK1040514A1 (en) 2002-06-14
CA2345286C (en) 2004-11-09
YU27801A (sh) 2003-04-30

Similar Documents

Publication Publication Date Title
HK1051681A1 (en) New process for the preparation of the trihydrate of the magnesium salt of s-omeprazole.
IL146105A (en) 5-pyridyl-1, 3-azole compounds, process for producing the same and use therefor
HK1098737A1 (en) Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane
GB2336364B (en) Paroxetine salt
IT1317741B1 (it) Metodo per la preparazione di 5-cianoftalide.
IT1319251B1 (it) Metodo per la preparazione di 5-carbossiftalide.
PL371059A1 (en) 5-phenylpyrimidines, agents comprising the same, method for production and use thereof
AU2003214902A1 (en) Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl.piperidin-1yl)-1-propanol compounds
ZA200300743B (en) DDS compound and process for the preparation thereof.
AU5038299A (en) Process for the biocidal treatment of surfaces
ZA200103320B (en) Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-phenylpiperidin-1-YL)-1-propanol.
HK1042484A1 (en) Processes for the preparation of (r)-a-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)-4-piperidinemethanol
ZA200103321B (en) Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-phenylpiperidin-1-YL)-1-propanol and intermediates useful therefor.
ITBO990128A0 (it) Maniglia cremonese multiuso per infissi .
HK1051190A1 (en) Process for the preparation of 2-(4-alkyl-1-piperazinyl-benzaldehyde and -benzylidenyl compounds.
IL164377A0 (en) Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
LT98110A (en) Polytetra-ammonium salt, method for preparation and use thereof
HUP0004052A3 (en) Improved process for the preparation of 1-(3-chloro-phenyl)-2-bromo-propane-1-one
HK1046901A1 (en) Process for the preparation of isotretinoin.
IT1318371B1 (it) Processo per la preparazione di eterocicli.
EP1398054A4 (en) METHOD OF ACCELERATING THE IMPROVEMENT OF THE SKIN BARRIER FUNCTION
IT1307295B1 (it) Procedimento per la preparazione di filati ondee o compensina.
GB0119324D0 (en) The hinge ripper & multi head hooly bar
ZA991907B (en) Novel processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol.
IT1304031B1 (it) Metodo per la preparazione di glucofanina.